Image of Saint Vincents Hospital Building

Dr. Erin Moore begins the latest in Abdominal Aortic Aneurysm treatment

23 January 2018. Dr. Erin Moore, MD FACS RPVI, Chief of Cardiothoracic and Vascular Surgery and Director of Vascular and Endovascular Surgery at Baptist Medical Center in Jacksonville, FL has enrolled his first two patients in the FDA trial for the Gore Excluder CEXC® conformable stent graft for the treatment of abdominal aortic aneurysms with an angulated infra-renal neck of 60-90 degrees.

Aortic aneurysms are abnormal dilations of the largest blood vessel in the body, which, if left untreated, can result in rupture and death.

These “angulated” aneurysms have been traditionally difficult to treat with the currently available devices on the market due to their straight design and relative rigidity and poor ability to be implanted in severely angulated aortic aneurysms.

Straight Anatomy                              Severely Angulated Anatomy

The current grafts available have a straight main body, while the new device allows the main body portion to “turn the corner” like a periscope, thereby seating the graft properly into the anatomy and creating the necessary seal to isolate any flow into the aneurysm sac.

Standard “straight” graft                                   New “Conformable” Graft

Dr. Moore and his team continue to push forward in the minimally invasive treatment of these aneurysms.

“This is an exciting time in aneurysm care”, says Dr. Moore. “We are able to bring yet another way to address aneurysm anatomy that has traditionally been difficult to treat with less invasive techniques. In many cases, patients were forced to undergo standard open repair with significantly increased recovery times and risks for secondary complications. I am gratified that we can offer this to my patients within this trial. We are bringing the future of aneurysm care to our patients NOW.”

Trial enrollment will continue into the near future until the necessary enrollment is completed for final FDA approval and widespread distribution.

Newer device gives surgeons flexibility in repairing abdominal aortic aneurysms

Click the following link to read the full article:

http://www.ctvsjax.com/wp-content/uploads/2017/02/AAA-Trials-Article.pdf

Mediscoop Magazine Featured Article Aortic Dissection

Click the following link to read the full article:

May-2016-Mediscoop-Miracle-Man2

The Doctor is In…local doctor Mark Mostovych on his career, hobbies and unique outlook on medicine

Click the following link for the full article:

Jacksonville Magazine Article

Dr. Erin Moore performs new angioplasty procedure at Baptist Medical Center Downtown

Clogged artery of a patient with peripheral artery disease The artery during a drug-coated balloon angioplasty procedure How the unclogged artery would look following the procedure
Clogged artery of a patient with peripheral artery disease
The artery during a drug-coated balloon angioplasty procedure
How the unclogged artery would look following the procedure

Patient ‘tickled pink’ after being first to undergo new angioplasty procedure at Baptist Medical Center Jacksonville

By Beth Reese Cravey Sun, Oct 19, 2014

For years, James Sanders could not manage the short walk from his home to his mailbox without severe pain in his right leg.

  His leg was always cold.

But Wednesday he was Baptist Medical Center Jacksonville’s first patient to undergo a new angioplasty treatment forperipheral artery disease, which had   caused his leg pain and circulatory problems. By Thursday, thanks to a tiny drug-coated balloon that reopens clogged arteries, he was feeling almost spry for his 68 years.

Provided by Baptist Health James Sanders, 68, of Savannah was the first patient to under go a new angioplasty treatment at Baptist Medical Center Jacksonville that uses a tiny drug-coated balloon to reopen arteries. Baptist was the first hospital in North Florida to use the procedure.
Provided by Baptist Health James Sanders, 68, of Savannah was the first patient to under go a new angioplasty treatment at Baptist Medical Center Jacksonville that uses a tiny drug-coated balloon to reopen arteries. Baptist was the first hospital in North Florida to use the procedure.

“I am very excited,” said Sanders, from his Savannah home. “It just tickles me pink.”

Millions of Americans suffer from peripheral artery disease, which causes fatty material to build up in the arteries carrying blood to the head, organs and limbs. If untreated, the disease can lead to severe blockage in the arteries of the legs or feet, and even amputation.

Baptist Health said its Jacksonville hospital was the first in North Florida to use the Lutonix 035 Drug Coated Balloon PTA Catheter, which allows medication to be released onto the inner surface of the artery to limit the amount of scarring that occurs following the procedure.

 

 

 

 

 

Surgeon Erin Moore performed the first Northeast Florida procedure using a tiny drug-coated balloon to reopen a clogged arteries and prevent recurrence.

 

Limiting scarring extends by several years the amount of time before the artery may become blocked again, said vascular surgeon Erin Moore, director of vascular and endovascular surgery at Baptist Medical Center Jacksonville, who performed the procedure on Sanders.

The standard treatment lasts one to two years; this new one, three to five years, he said.

 

 

 

 

“Our hope for these patients is that when we do an intervention it will last longer,” Moore said. “We are doing something that has more longevity and more durability.”

 

In typical angioplasty, a doctor threads a thin tube through a blood vessel in the arm or groin up to the blockage, then inflates a tiny balloon at the end of the tube to push the plaque outward against the wall of the artery. This widens the artery and restores blood flow. The new treatment adding a low-dose coating of Paclitaxel to the balloon was recently approved by the U.S. Food and Drug Administration.

Paclitaxel is also used in cancer chemotherapy.

“It is a cell-killing medication,” Moore said, and when used in arteries kills “the cells responsible for creating scarring.”

Nonclinical testing and three clinical studies showed the safety and effectiveness of the Lutonix drug-coated balloon, according to an FDA news release.

Provided by Baptist Health Erin Moore, director of vascular and endovascular surgery at Baptist Medical Center Jacksonville, (right) stands by after completing a new angioplasty procedure using a tiny drug-coated balloon to reopen a Savannah patient's clogged arteries. The procedure was a first for Northeast Florida. At left is Shaun Brazil, a representative for C.R. Bard, manufucturer of the Lutonix balloon catheter used in the procedure.
Provided by Baptist Health Erin Moore, director of vascular and endovascular surgery at Baptist Medical Center Jacksonville, (right) stands by after completing a new angioplasty procedure using a tiny drug-coated balloon to reopen a Savannah patient’s clogged arteries. The procedure was a first for Northeast Florida. At left is Shaun Brazil, a representative for C.R. Bard, manufucturer of the Lutonix balloon catheter used in the procedure.

“Peripheral artery disease can be quite serious. Preventing further blockage of arteries is just as important as removing the initial blockage,” said William Maisel, deputy director for science and chief scientist in the FDA’s Center for Devices and Radiological Health. “The clinical data show that Lutonix … may be more effective than traditional balloon angioplasty at helping to prevent further blockage.”

Sanders, diagnosed with diabetes in 1995, had been dealing with right leg pain from peripheral artery disease and a wound on his right ankle. In 2013 in Georgia, he underwent a different procedure to open up his arteries, but it failed.

He was thrilled with the work of the drug-coated balloon.

“This is the first day my leg has been warm in years,” he said. “The last one didn’t work. … They got blocked again. When they told me this would work, I was excited about that.”

Sanders said he did not mind being Baptist’s first patient for the new procedure.

“It seemed to me to be a good thing,” he said. “I feel lucky. … I hope it can help others, too.”

 

Click Here for the Article

HealthSource Magazine Featured Article

Click Here to ExpandClick Here to ExpandClick Here to Expand

JacksonvilleMag.com Featured Article

Jacksonvillemag.com article

Dr. Nathan Bates performs daVinci Robot first-of-a-kind procedure at Orange Park Medical Center

Mitral valve repair and replacement performed with a daVinci Robot, is a first-of-a-kind leading edge procedure being performed at Orange Park Medical Center – the only location north of Miami and south of Atlanta where it is currently being offered in the Southeast. Learn more by watching this video. [Click Here]

St. Vincent’s Riverside First in the Region to Offer Transcatheter Aortic Valve Replacement Therapy

Read the Interview with Dr. Mostovych Here.

 

St. Vincent's Riverside

Dr. Bates Performs Robotic Mitral Valve Surgery

A cutting edge medical procedure is now available in Clay County.

Read the Article Here.

 

Dr. Nathan Bates Performing Robotic Mitral Valve Surgery

Copyright © 2018 Cardiothoracic and Vascular Surgical Associates of Jacksonville, Florida. All Rights Reserved.

Cardiothoracic & Vascular Surgical Associates is committed to keeping our site accessible to all visitors. We welcome feedback on ways to improve the site's accessibility so it is convenient for everyone to navigate.

(904) 384-3343

Email us

Elyk Innovation | Web Design Company located in Jacksonville Florida | Opens in new tab